Exabis Library
Welcome to the e-CCO Library!
P763: Fucosyltransferase 2 non-secretor status in Crohn's disease: a prospective observational analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P763: Quality of life in Paediatric inflammatory bowel disease Patient: How well do we understand patients?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P763: Role of quality of life in patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P764 Phenotypic analysis of patients with inflammatory bowel disease: 23 year data of a centre in a South American country
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P764: Drug level thresholds in patients with Crohn’s disease on dose-intensified anti-TNF therapy predict intestinal wall healing for infliximab but not adalimumab
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P764: Effectiveness and safety of COVID-19 Vaccine among Patients with Inflammatory Bowel Disease: A medical center hospital-based study in central Taiwan
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P764: Prevalence of Autoimmune diseases among first- and second-degree relatives of patients with inflammatory bowel diseases. A case–control survey in Israel
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P764: Response to thiopurines is independent of ATG16L1 genotype
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P765 Fatigue as one of the most important symptoms in adult patients with inflammatory bowel disease: Croatian tertiary centre pilot study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P765: A description of inflammatory bowel disease patients’ beliefs in their medications, in comparison with patients with other chronic conditions
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P765: Role of C-reactive protein kinetics after surgery for Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P765: Tolerating infliximab therapeutic drug monitoring without anti-drug antibodies – an argument for drug intolerant assays?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P765: Transcriptome of intestinal epithelial barrier genes in the colonic mucosa from patients with ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P766 ABO blood groups and ulcerative colitis: A hospital-based study in central Taiwan
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P766: Combination therapy of fresh fecal microbial transplantation and antibiotics for ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P766: Differences among disease pattern, medication use, surgery and hospitalisation rates in a low prevalence of ulcerative colitis population: A retrospective cohort from Bangkok, Thailand
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P766: Practical application of evidence-based dietary therapy into inflammatory bowel disease care shows high patient satisfaction, compliance, and efficacy. The Delectable Program
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P766: Quantum Blue® fCAL extended POC user performance evaluation
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P767 Prevalence and incidence rates of inflammatory bowel disease among First Nations: Population-based evidence from Saskatchewan, Canada
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P767: Intestinal ultrasonography predicts short term clinical remission in patients with moderate-to-severe ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM